Palivizumab 100mg/1ml solution for injection vials

SNOMED code
30319111000001102
Active compound
Palivizumab
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
1 ml, vial
Ingredients
Palivizumab — 100 mg / 1 ml based on ingredient substance
Form & Route
solutioninjection.intramuscular
Solution for injection, Intramuscular
Controlled drug
No Controlled Drug Status

Products

Synagis 100mg/1ml solution for injection vials (AstraZeneca UK Ltd)

Synagis 100mg/1ml solution for injection vials

SNOMED code
30251611000001107
Supplier
AstraZeneca UK Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
None
Licensed route
Intramuscular
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Synagis 100mg/1ml solution for injection vials (AstraZeneca UK Ltd) 1 vial
30251711000001103   ref. pack
💯 Available

Legal category: POM
8054083007113

End: 08054083007113

End: 08054083019338

End: 08054083009957

End: 5000456066723
NHS Indicative Price
£563.64
• Personally Administered
  • • Prescription Charges
  • • Dispensing Fees
  • • Special container
  • • Discount not deducted - automatic

Reference packs

Palivizumab 100mg/1ml solution for injection vials 1 vial
SNOMED code
30251511000001108
Quantity and unit
1 vial
Packs